Why Switzerland Why Switzerland The remarkable chemical-pharmaceutical industry in the canton of Valais
Life sciences GliaPharm receives USD 4.2 million to propel Alzheimer’s treatment development 20 December 2023
Life sciences Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry 4 December 2023
Life sciences Life sciences Vaud-based LAGOSTA and global giant Merck collaborate on chitosan distribution 2 November 2023
Life sciences Bacthera’s Visp plant aims to revolutionize microbiome-based treatments 30 October 2023